Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
for
Pain, Postoperative, Rib Fracture Multiple
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18 - 70+
Code: NCT05415384
Recruiting
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
for
Parkinson Disease, Multiple System Atrophy,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0+
Code: NCT03872102
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Fall Risk Reduction in Multiple Sclerosis (FIRMS)
for
Multiple Sclerosis
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign
Sex: All
Age: 18 - 64
Code: NCT02314585
Recruiting
New
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice
for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07779460
Recruiting
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Pittsburgh PA, Irvine CA, Duarte CA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07156227
Phase1, Recruiting
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
for
Plasma Cell Myeloma Refractory
Location: Sherbrooke, Hackensack NJ, Montreal, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06630806
Phase1, Recruiting
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07137416
Phase1, Recruiting
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
for
Plasma Cell Myeloma Refractory
Location: Buffalo NY, Columbus OH, Atlanta GA, Ann Arbor MI
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT04643002
Phase1, Phase2, Recruiting
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
for
Multiple Myeloma,
Location: Miami FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT07446777
Recruiting
Registry for Adults With Plasma Cell Disorders (PCD's)
for
Multiple Myeloma, Amyloidosis, Cryoglobulinemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT03717844
Recruiting
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 60+
Code: NCT06296368
Recruiting
Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
for
Multiple Myeloma, Non-Hodgkins Lymphoma
Location: New York NY
Sponsor: Shi, Patricia, M.D.
Sex: All
Age: 18 - 70+
Code: NCT01042717
Recruiting
Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma
for
Multiple Myeloma and Plasma Cell Neoplasm
Location: New York NY, San Francisco CA
Sponsor: Herbert Irving Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT00334932
Phase1, Phase2, Recruiting
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
for
Multiple Myeloma
Location: Miami FL
Sponsor: Carl Ola Landgren, MD, PhD
Sex: All
Age: 18+
Code: NCT06100237
Phase2, Recruiting
New
Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing
for
Multiple Myeloma
Location: Nashville TN
Sponsor: Eden Biltibo
Sex: All
Age: 18 - 70
Code: NCT07485647
Phase2, Recruiting
Active & Responsive
Microelectrode Recordings From the Vagus Nerve in Awake Humans